Entrada Therapeutics, Inc. (TRDA)
Nasdaq: TRDA · Pharmaceutical Preparations · Boston, MA · filing with the SEC since 2016
Who runs Entrada Therapeutics, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Doshi Dipal
CEO. First filing Oct 2021, latest Sep 3, 2026, 27 filings in all.
Officers reporting now
4
of 11 people with a filing in the last fifteen months
Directors reporting now
7
14 people on the record since 2021
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Doshi Dipal | CEO | Oct 2021 | Sep 3, 2026 | none |
| Dowden Nathan J | President & COO | Oct 2021 | Sep 3, 2026 | 3 · $400,000 |
| Sethuraman Natarajan | President, Research & Develop. | Oct 2021 | Sep 3, 2026 | 1 · $400,000 |
| Wentworth Kory James | Chief Financial Officer | Oct 2021 | Sep 3, 2026 | 5 · $400,000 |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Foley Todd | director | Oct 2021 | Sep 9, 2026 | 3 · $500,000 |
| Parmar Kush | director | Oct 2021 | Aug 10, 2026 | 6 · $3.6M |
| Chapman Gina | director | Sep 2023 | Jun 12, 2026 | none |
| Kim Peter S | director | Oct 2021 | Jun 12, 2026 | none |
| Radhakrishnan Maha | director | Jun 2025 | Jun 12, 2026 | none |
| Thistle Mary | director | Oct 2021 | Jun 12, 2026 | none |
| Zeiher Bernhardt G | director | Apr 2023 | Jun 12, 2026 | none |
Owners of more than 10% of a classsales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Evnin Luke | 10% owner | Oct 2021 | Sep 9, 2026 | none |
| Gadicke Ansbert | 10% owner | Oct 2021 | Sep 9, 2026 | none |
| Mpm Asset Management Investors Bv2014 LLC | 10% owner | Oct 2021 | Sep 9, 2026 | none |
| Mpm Asset Management Investors Bv2018 LLC | 10% owner | Oct 2021 | Sep 9, 2026 | none |
| Mpm Bioventures 2014 (B), L.P. | 10% owner | Oct 2021 | Sep 9, 2026 | 3 · $600,000 |
| Mpm Bioventures 2014 Gp LLC | 10% owner | Oct 2021 | Sep 9, 2026 | 3 · $600,000 |
| Mpm Bioventures 2014 LLC | 10% owner | Oct 2021 | Sep 9, 2026 | none |
| Mpm Bioventures 2014, L.P. | 10% owner | Oct 2021 | Sep 9, 2026 | none |
| Mpm Bioventures 2018 (B), L.P. | 10% owner | Oct 2021 | Sep 9, 2026 | 3 · $1.9M |
| Mpm Bioventures 2018 Gp LLC | 10% owner | Oct 2021 | Sep 9, 2026 | 3 · $1.9M |
| Mpm Bioventures 2018 LLC | 10% owner | Oct 2021 | Sep 9, 2026 | 9 · $1.7M |
| Mpm Bioventures 2018, L.P. | 10% owner | Oct 2021 | Sep 9, 2026 | none |
| 5am Opportunities I (Gp), LLC | 10% owner | Oct 2021 | Aug 10, 2026 | none |
| 5am Opportunities I, L.P. | 10% owner | Oct 2021 | Aug 10, 2026 | none |
| 5am Partners V, LLC | 10% owner | Oct 2021 | Aug 10, 2026 | none |
| 5am Ventures V, L.P. | 10% owner | Oct 2021 | Aug 10, 2026 | 1 · $1.8M |
| Rocklage Scott M | 10% owner | Oct 2021 | Aug 10, 2026 | 4 · $1.2M |
| Schwab Andrew J. | 10% owner | Oct 2021 | Aug 10, 2026 | none |
| Baker Bros. Advisors (Gp) LLC | 10% owner | Dec 2021 | Nov 24, 2025 | none |
| Baker Bros. Advisors LP | 10% owner | Dec 2021 | Nov 24, 2025 | none |
Earlier names on the record3, newest filing first
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.